Status:
COMPLETED
Vagus Somatosensory Evoked Potentials and Near-infrared Spectroscopy in the Early Diagnosis of Dementia
Lead Sponsor:
University of Wuerzburg
Conditions:
Alzheimer´s Disease
Eligibility:
All Genders
70-78 years
Brief Summary
In its long preclinical course, AD shows a spreading pattern of specific pathology in a uniform sequence of predictable steps including brainstem nuclei in early stages. Many of these nuclei which are...
Detailed Description
With the increasing life span of our population, the prevalence of dementia syndromes is increasing. The most frequent cause of dementia is Alzheimer´s disease (AD), and still, it is not curable. Thus...
Eligibility Criteria
Inclusion
- inhabitant of Wuerzburg
- born between 1.4.1936 and 31.3.1941
- able to give informed consent
Exclusion
- manifestation of - apart from dementia - other severe psychiatric disease such as Schizophrenia, neurologic disease such as Parkinson´s disease or stroke or intern disease such as cancer within the past 12 months
- severe, uncorrected see or hearing disturbance
Key Trial Info
Start Date :
June 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2023
Estimated Enrollment :
604 Patients enrolled
Trial Details
Trial ID
NCT02224326
Start Date
June 1 2011
End Date
January 1 2023
Last Update
October 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Clinic Wuerzburg
Würzburg, Germany, D-97080